You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 24, 2024

NEO-MEDROL Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

When do Neo-medrol patents expire, and what generic alternatives are available?

Neo-medrol is a drug marketed by Pharmacia And Upjohn and is included in two NDAs.

The generic ingredient in NEO-MEDROL is methylprednisolone acetate; neomycin sulfate. There are forty drug master file entries for this compound. Additional details are available on the methylprednisolone acetate; neomycin sulfate profile page.

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for NEO-MEDROL?
What are the global sales for NEO-MEDROL?
What is Average Wholesale Price for NEO-MEDROL?

Summary for NEO-MEDROL

US Patents:	0
Applicants:	1
NDAs:	2
Clinical Trials:	122
DailyMed Link:	NEO-MEDROL at DailyMed

Drug patent expirations by year for NEO-MEDROL

Recent Clinical Trials for NEO-MEDROL

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Zheng Liu	N/A
Brii Biosciences Limited	Phase 2
Emory University	Phase 4

See all NEO-MEDROL clinical trials

US Patents and Regulatory Information for NEO-MEDROL

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pharmacia And Upjohn	NEO-MEDROL	methylprednisolone; neomycin sulfate	OINTMENT;OPHTHALMIC	060645-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Pharmacia And Upjohn	NEO-MEDROL ACETATE	methylprednisolone acetate; neomycin sulfate	CREAM;TOPICAL	060611-002	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Pharmacia And Upjohn	NEO-MEDROL ACETATE	methylprednisolone acetate; neomycin sulfate	CREAM;TOPICAL	060611-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.